These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A. Westerhof W; Nieuweboer-Krobotova L Arch Dermatol; 1997 Dec; 133(12):1525-8. PubMed ID: 9420536 [TBL] [Abstract][Full Text] [Related]
3. Psoralen and ultraviolet A and narrow-band ultraviolet B in inducing stability in vitiligo, assessed by vitiligo disease activity score: an open prospective comparative study. Bhatnagar A; Kanwar AJ; Parsad D; De D J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1381-5. PubMed ID: 17958845 [TBL] [Abstract][Full Text] [Related]
4. Photochemotherapy (PUVA) in psoriasis and vitiligo. Shenoi SD; Prabhu S; Indian J Dermatol Venereol Leprol; 2014; 80(6):497-504. PubMed ID: 25382505 [TBL] [Abstract][Full Text] [Related]
5. An objective assessment of melanin in vitiligo skin treated with Balneo PUVA therapy. Hegyi V; Petrovajová M; Novotný M Skin Res Technol; 2014 Feb; 20(1):108-15. PubMed ID: 23800185 [TBL] [Abstract][Full Text] [Related]
6. Comparison of systemic PUVA and NB-UVB in the treatment of vitiligo: an open prospective study. Bhatnagar A; Kanwar AJ; Parsad D; De D J Eur Acad Dermatol Venereol; 2007 May; 21(5):638-42. PubMed ID: 17447977 [TBL] [Abstract][Full Text] [Related]
12. Comparison of efficacy and side-effect profile of oral PUVA vs. oral PUVA sol in the treatment of vitiligo: a 36-week prospective study. Singh S; Khandpur S; Sharma VK; Ramam M J Eur Acad Dermatol Venereol; 2013 Nov; 27(11):1344-51. PubMed ID: 23066663 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of local psoralen ultraviolet A treatments in psoriasis, vitiligo and eczema. Adişen E; Karaca F; Oztaş M; Gürer MA Clin Exp Dermatol; 2008 May; 33(3):344-5. PubMed ID: 18093241 [No Abstract] [Full Text] [Related]
14. Outdoor and office photochemotherapy of vitiligo: a comparison. Wennersten G; Hägermark O Photodermatol; 1984 Apr; 1(2):91-3. PubMed ID: 6531288 [TBL] [Abstract][Full Text] [Related]
15. How we treat vitiligo. Kenney JA; Grimes PE Cutis; 1983 Oct; 32(4):347-8. PubMed ID: 6627994 [TBL] [Abstract][Full Text] [Related]
16. Experience with calcipotriol as adjunctive treatment for vitiligo in patients who do not respond to PUVA alone: a preliminary study. Yalçin B; Sahin S; Bükülmez G; Karaduman A; Atakan N; Akan T; Kölemen F J Am Acad Dermatol; 2001 Apr; 44(4):634-7. PubMed ID: 11260538 [TBL] [Abstract][Full Text] [Related]
17. Multiple keratoses and squamous carcinoma after PUVA treatment of vitiligo. Buckley DA; Rogers S Clin Exp Dermatol; 1996 Jan; 21(1):43-5. PubMed ID: 8689768 [TBL] [Abstract][Full Text] [Related]
18. Dermatology Life Quality Index score in vitiligo and its impact on the treatment outcome. Parsad D; Pandhi R; Dogra S; Kanwar AJ; Kumar B Br J Dermatol; 2003 Feb; 148(2):373-4. PubMed ID: 12588405 [No Abstract] [Full Text] [Related]